Cai X, Han X, Luo Y, et al : Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients : A meta-analysis. J Diabetes 7 :347-359, 2015
Nomiyama T, Akehi Y, Takenoshita H, et al : Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 95: e27-28, 2012
Kozlovski P, Bhosekar V, Foley JE : DPP-4 inhibitor treatment : β-cell response but not HbA1c reduction is dependent on the duration of diabetes. Vasc Health Risk Manag 13 : 123-126, 2017